Gender-specific differences in bladder cancer: a retrospective analysis.

BACKGROUND A higher incidence of bladder cancer has been reported in men compared with women. Clinical gender differences have been observed but are less well described. OBJECTIVE This retrospective analysis further examines clinical differences in the development and manifestation of bladder cancer between men and women. METHODS Consecutive male and female patients with bladder cancer treated between 1969 and 1997 at a single center (University Hospital of Innsbruck, Innsbruck, Austria) were included in the study. Patient characteristics regarding age, tumor classification, localization, and recurrence were compared between male and female patients. Statistical analysis was conducted using the t test, the chi(2) test, and the Kaplan-Meier method, with the log-rank test for subgroup analysis. RESULTS In the 1,269 patients (876 men, 393 women) who were examined, 1,744 tumors were found. The male-to-female bladder cancer incidence ratio was 2.2:1. Tumors were diagnosed at a significantly younger age in men than in women (mean age: 62 years vs 67 years, respectively; P < 0.001). No difference in the histology of tumors was observed between the sexes. Muscle-invasive tumors more frequently occurred in men than in women (39.8% vs 34.5%; P = NS). In men compared with women, primary tumors were more aggressive (grade 2, 36.6% vs 28.2%; P < 0.001) and tumor recurrences were more invasive (59.0% vs 57.8%; P = NS). Tumors were more often located in the urethra in men than in women (43 [3.4%] vs 9 [1.8%]; P = 0.034), the trigonum (246 [19.8%] vs 75 [14.9%]; P < 0.001), and the bladder dome or vault (128 [10.3%] vs 37 [7.4%]; P = 0.015). Generally, no difference in survival rate was observed between the sexes; only in the subgroup of muscle-invasive tumors (n = 455) did women have a worse overall survival rate than did men (P = 0.022). CONCLUSIONS Clinical gender differences in bladder cancer appear to have a higher incidence in men than in women. In this analysis, women were older at the age of detection, but had less-invasive and less-aggressive tumors than did men. However, women with muscle-invasive disease had a worse overall survival rate than did men in the same subset.

[1]  Lawrence D. True,et al.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .

[2]  L. Kiemeney,et al.  Gender differences in stage-adjusted bladder cancer survival. , 2000, Urology.

[3]  J. Ferlay,et al.  Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  M. Curwen,et al.  The site of recurrence of non-infiltrating bladder tumours. , 1978, British journal of urology.

[5]  C. Lynch,et al.  Bladder cancer, parity, and age at first birth , 2004, Cancer Causes & Control.

[6]  E Lynge,et al.  Work-related cancer in the Nordic countries. , 1999, Scandinavian journal of work, environment & health.

[7]  E. Messing,et al.  Gender, racial and age differences in bladder cancer incidence and mortality. , 2004, Urologic oncology.

[8]  G. Steineck,et al.  Epidemiology and Etiology of Premalignant and Malignant Urothelial Changes , 2000, Scandinavian journal of urology and nephrology. Supplementum.

[9]  J. Chang-Claude,et al.  Occupation and bladder cancer in European women , 1999, Cancer Causes & Control.

[10]  P. Babb,et al.  Current trends in bladder cancer in England and Wales. , 2004, The Journal of urology.

[11]  G. Bartsch,et al.  Incidence of urethral tumor involvement in 910 men with bladder cancer , 2004, World Journal of Urology.

[12]  D. Michaud,et al.  Hormonal and reproductive factors and the risk of bladder cancer in women. , 2006, American journal of epidemiology.

[13]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[14]  A. Stewart,et al.  The National Cancer Data Base report on bladder carcinoma , 1996, Cancer.

[15]  A. Schatzkin,et al.  Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study , 2006, International journal of cancer.

[16]  E M Barbeau,et al.  Smoking, social class, and gender: what can public health learn from the tobacco industry about disparities in smoking? , 2004, Tobacco Control.

[17]  V. Steele,et al.  Development of chemopreventive agents for bladder cancer , 1992, Journal of cellular biochemistry. Supplement.

[18]  H. G. van der Poel,et al.  Gender differences in stage distribution of bladder cancer. , 2000, Urology.

[19]  J. Chang-Claude,et al.  Occupation and bladder cancer among men in Western Europe , 2003, Cancer Causes & Control.

[20]  Núria Malats,et al.  Smoking and Bladder Cancer in Spain: Effects of Tobacco Type, Timing, Environmental Tobacco Smoke, and Gender , 2006, Cancer Epidemiology Biomarkers & Prevention.

[21]  W. M. Linehan,et al.  Unexplained excess risk of bladder cancer in men. , 1990, Journal of the National Cancer Institute.

[22]  J. Chang-Claude,et al.  Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case‐control studies , 2000, International journal of cancer.

[23]  S. Felknor,et al.  An Updated Review of the Literature: Risk Factors for Bladder Cancer with Focus on Occupational Exposures , 2006, Southern medical journal.

[24]  Matthew J Hayat,et al.  Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. , 2007, The oncologist.

[25]  L. Kiemeney,et al.  Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989. , 1994, European journal of cancer.

[26]  J. Chang-Claude,et al.  The contribution of cigarette smoking to bladder cancer in women (pooled European data) , 2001, Cancer Causes & Control.